Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
Willscott E. Naugler,1,2
Toshiharu Sakurai,1
Sunhwa Kim,1
Shin Maeda,3
KyoungHyun Kim,1
Ahmed M. Elsharkawy,1,4
Michael Karin1*
Abstract:
Hepatocellular carcinoma (HCC), the most common liver cancer,occurs mainly in men. Similar gender disparity is seen in micegiven a chemical carcinogen, diethylnitrosamine (DEN). DEN administrationcaused greater increases in serum interleukin-6 (IL-6) concentrationin males than it did in females. Furthermore, ablation of IL-6abolished the gender differences in hepatocarcinogenesis inmice. DEN exposure promoted production of IL-6 in Kupffer cells(KCs) in a manner dependent on the Toll-like receptor adaptorprotein MyD88, ablation of which also protected male mice fromDEN-induced hepatocarcinogenesis. Estrogen inhibited secretionof IL-6 from KCs exposed to necrotic hepatocytes and reducedcirculating concentrations of IL-6 in DEN-treated male mice.We propose that estrogen-mediated inhibition of IL-6 productionby KCs reduces liver cancer risk in females, and these findingsmay be used to prevent HCC in males.
1 Laboratory of Gene Regulation and Signal Transduction, Department of Pharmacology and Cancer Center, University of California, San Diego, CA 93093, USA. 2 Department of Medicine, Division of Gastroenterology, University of California, San Diego, CA 93093, USA. 3 Division of Gastroenterology, The Institute for Adult Diseases, Asahi Life Foundation, 1-6-1 Marunouchi, Chiyoda-ku, Tokyo 100-0005, Japan. 4 Liver Research Group, University of Newcastle, Newcastle Upon Tyne NE2 4HH, UK.
* To whom correspondence should be addressed: 9500 Gilman Road, Mail Code 0723 University of California, San Diego, San Diego, CA 920930636, USA. E-mail: karinoffice{at}ucsd.edu
The editors suggest the following Related Resources on Science sites:
In Science Magazine
PERSPECTIVES
Toby Lawrence, Thorsten Hageman, and Frances Balkwill (6 July 2007) Science317 (5834), 51.
[DOI: 10.1126/science.1146052] |Summary »|Full Text »|PDF »
In Science Signaling
EDITORS' CHOICE
L. Bryan Ray (10 July 2007) Sci. STKE2007 (394), tw246.
[DOI: 10.1126/stke.3942007tw246] |Abstract »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Oestrogens promote tumorigenesis in a mouse model for colitis-associated cancer.
J. Heijmans, M. C. B. Wielenga, S. L. Rosekrans, J. F. van Lidth de Jeude, J. Roelofs, P. Groothuis, A. Ederveen, E. S. M. de Jonge-Muller, I. Biemond, J. C. H. Hardwick, et al. (2013)
Gut
|Abstract »|Full Text »
Alteration of the Serum N-glycome of Mice Locally Exposed to High Doses of Ionizing Radiation.
T. Chaze, M.-C. Slomianny, F. Milliat, G. Tarlet, T. Lefebvre-Darroman, P. Gourmelon, E. Bey, M. Benderitter, J.-C. Michalski, and O. Guipaud (2013)
Mol. Cell. Proteomics
12, 283-301
|Abstract »|Full Text »|PDF »
Proinflammatory Homeobox Gene, ISX, Regulates Tumor Growth and Survival in Hepatocellular Carcinoma.
S.-H. Hsu, L.-T. Wang, K.-T. Lee, Y.-L. Chen, K.-Y. Liu, J.-L. Suen, C.-Y. Chai, and S.-N. Wang (2013)
Cancer Res.
73, 508-518
|Abstract »|Full Text »|PDF »
MyD88: A Critical Adaptor Protein in Innate Immunity Signal Transduction.
N. Warner and G. Nunez (2013)
J. Immunol.
190, 3-4
|Full Text »|PDF »
p38{alpha} Inhibits Liver Fibrogenesis and Consequent Hepatocarcinogenesis by Curtailing Accumulation of Reactive Oxygen Species.
T. Sakurai, M. Kudo, A. Umemura, G. He, A. M. Elsharkawy, E. Seki, and M. Karin (2013)
Cancer Res.
73, 215-224
|Abstract »|Full Text »|PDF »
Gender Differences in Chemical Carcinogenesis in National Toxicology Program 2-Year Bioassays.
S. Kadekar, S. Peddada, I. Silins, J. E. French, J. Hogberg, and U. Stenius (2012)
Toxicol Pathol
40, 1160-1168
|Abstract »|Full Text »|PDF »
Estrogen Represses Hepatocellular Carcinoma (HCC) Growth via Inhibiting Alternative Activation of Tumor-associated Macrophages (TAMs).
W. Yang, Y. Lu, Y. Xu, L. Xu, W. Zheng, Y. Wu, L. Li, and P. Shen (2012)
J. Biol. Chem.
287, 40140-40149
|Abstract »|Full Text »|PDF »
Resveratrol inhibits LPS-induced epithelial-mesenchymal transition in mouse melanoma model.
M.-C. Chen, W.-W. Chang, Y.-D. Kuan, S.-T. Lin, H.-C. Hsu, and C.-H. Lee (2012)
Innate Immunity
18, 685-693
|Abstract »|Full Text »|PDF »
Does Childhood Misfortune Increase Cancer Risk in Adulthood?.
P. M. Morton, M. H. Schafer, and K. F. Ferraro (2012)
J Aging Health
24, 948-984
|Abstract »|PDF »
The Great Escape: Microbiotal LPS Takes a Toll on the Liver.
A Single Neonatal Exposure to Aflatoxin B1 Induces Prolonged Genetic Damage in Two Loci of Mouse Liver.
R. Wattanawaraporn, L. L. Woo, C. Belanger, S.-c. Chang, J. E. Adams, L. J. Trudel, J. T. Bouhenguel, P. A. Egner, J. D. Groopman, R. G. Croy, et al. (2012)
Toxicol. Sci.
128, 326-333
|Abstract »|Full Text »|PDF »
Induction of hepatocellular carcinoma by in vivo gene targeting.
P.-R. Wang, M. Xu, S. Toffanin, Y. Li, J. M. Llovet, and D. W. Russell (2012)
PNAS
109, 11264-11269
|Abstract »|Full Text »|PDF »
Inorganic mercury exposure in prairie voles (Microtus ochrogaster) alters the expression of toll-like receptor 4 and activates inflammatory pathways in the liver in a sex-specific manner.
S. Assefa, J. Curtis, S. Sethi, R. Davis, Y. Chen, and R. Kaul (2012)
Human and Experimental Toxicology
31, 376-386
|Abstract »|Full Text »|PDF »
Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma.
V. Chew, J. Chen, D. Lee, E. Loh, J. Lee, K. H. Lim, A. Weber, K. Slankamenac, R. T. P. Poon, H. Yang, et al. (2012)
Gut
61, 427-438
|Abstract »|Full Text »|PDF »
Metastatic Cells Can Escape the Proapoptotic Effects of TNF-{alpha} through Increased Autocrine IL-6/STAT3 Signaling.
Diethylnitrosamine-induced hepatocarcinogenesis is suppressed in lecithin:retinol acyltransferase-deficient mice primarily through retinoid actions immediately after carcinogen administration.
Y. Shirakami, M. E. Gottesman, and W. S. Blaner (2012)
Carcinogenesis
33, 268-274
|Abstract »|Full Text »|PDF »
2-Amino-3-Methylimidazo[4,5-f]Quinoline (IQ) Promotes Mouse Hepatocarcinogenesis by Activating Transforming Growth Factor-{beta} and Wnt/{beta}-Catenin Signaling Pathways.
X.-L. Xie, M. Wei, A. Kakehashi, S. Yamano, M. Tajiri, and H. Wanibuchi (2012)
Toxicol. Sci.
125, 392-400
|Abstract »|Full Text »|PDF »
Interleukin-11 Links Oxidative Stress and Compensatory Proliferation.
T. Nishina, S. Komazawa-Sakon, S. Yanaka, X. Piao, D.-M. Zheng, J.-H. Piao, Y. Kojima, S. Yamashina, E. Sano, T. Putoczki, et al. (2012)
Science Signaling
5, ra5
|Abstract »|Full Text »|PDF »
JNK-Induced Apoptosis, Compensatory Growth, and Cancer Stem Cells.
CUEDC2 (CUE Domain-containing 2) and SOCS3 (Suppressors of Cytokine Signaling 3) Cooperate to Negatively Regulate Janus Kinase 1/Signal Transducers and Activators of Transcription 3 Signaling.
W.-N. Zhang, L. Wang, Q. Wang, X. Luo, D.-F. Fang, Y. Chen, X. Pan, J.-H. Man, Q. Xia, B.-F. Jin, et al. (2012)
J. Biol. Chem.
287, 382-392
|Abstract »|Full Text »|PDF »
A Critical Role for Macrophages in Promotion of Urethane-Induced Lung Carcinogenesis.
R. Zaynagetdinov, T. P. Sherrill, V. V. Polosukhin, W. Han, J. A. Ausborn, A. G. McLoed, F. B. McMahon, L. A. Gleaves, A. L. Degryse, G. T. Stathopoulos, et al. (2011)
J. Immunol.
187, 5703-5711
|Abstract »|Full Text »|PDF »
CDC23 regulates cancer cell phenotype and is overexpressed in papillary thyroid cancer.
L. Zhang, R. Rahbari, M. He, and E. Kebebew (2011)
Endocr. Relat. Cancer
18, 731-742
|Abstract »|Full Text »|PDF »
Sex differences in resident immune cell phenotype underlie more efficient acute inflammatory responses in female mice.
R. S. Scotland, M. J. Stables, S. Madalli, P. Watson, and D. W. Gilroy (2011)
Blood
118, 5918-5927
|Abstract »|Full Text »|PDF »
Evolution of the TIR Domain-Containing Adaptors in Humans: Swinging between Constraint and Adaptation.
S. Fornarino, G. Laval, L. B. Barreiro, J. Manry, E. Vasseur, and L. Quintana-Murci (2011)
Mol. Biol. Evol.
28, 3087-3097
|Abstract »|Full Text »|PDF »
Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer.
J. Coward, H. Kulbe, P. Chakravarty, D. Leader, V. Vassileva, D. A. Leinster, R. Thompson, T. Schioppa, J. Nemeth, J. Vermeulen, et al. (2011)
Clin. Cancer Res.
17, 6083-6096
|Abstract »|Full Text »|PDF »
Human serum N-glycan profiles are age and sex dependent.
N. Ding, H. Nie, X. Sun, W. Sun, Y. Qu, X. Liu, Y. Yao, X. Liang, C. C. Chen, and Y. Li (2011)
Age Ageing
40, 568-575
|Abstract »|Full Text »|PDF »
Absence of hepatic stellate cell retinoid lipid droplets does not enhance hepatic fibrosis but decreases hepatic carcinogenesis.
J. Kluwe, N. Wongsiriroj, J. S. Troeger, G.-Y. Gwak, D. H. Dapito, J.-P. Pradere, H. Jiang, M. Siddiqi, R. Piantedosi, S. M. O'Byrne, et al. (2011)
Gut
60, 1260-1268
|Abstract »|Full Text »|PDF »
CXCR3 Enhances a T-Cell-Dependent Epidermal Proliferative Response and Promotes Skin Tumorigenesis.
A. E. Winkler, J. J. Brotman, M. E. Pittman, N. P. Judd, J. S. Lewis Jr, R. D. Schreiber, and R. Uppaluri (2011)
Cancer Res.
71, 5707-5716
|Abstract »|Full Text »|PDF »
Exercise-induced muscle-derived cytokines inhibit mammary cancer cell growth.
P. Hojman, C. Dethlefsen, C. Brandt, J. Hansen, L. Pedersen, and B. K. Pedersen (2011)
Am J Physiol Endocrinol Metab
301, E504-E510
|Abstract »|Full Text »|PDF »
17{beta}-Estradiol and Tamoxifen Prevent Gastric Cancer by Modulating Leukocyte Recruitment and Oncogenic Pathways in Helicobacter Pylori-Infected INS-GAS Male Mice.
A. Sheh, Z. Ge, N. M. A. Parry, S. Muthupalani, J. E. Rager, A. R. Raczynski, M. W. Mobley, A. F. McCabe, R. C. Fry, T. C. Wang, et al. (2011)
Cancer Prevention Research
4, 1426-1435
|Abstract »|Full Text »|PDF »
miR-22 Promotes HBV-Related Hepatocellular Carcinoma Development in Males.
R. Jiang, L. Deng, L. Zhao, X. Li, F. Zhang, Y. Xia, Y. Gao, X. Wang, and B. Sun (2011)
Clin. Cancer Res.
17, 5593-5603
|Abstract »|Full Text »|PDF »
The role for estrogen receptor-alpha and prolactin receptor in sex-dependent DEN-induced liver tumorigenesis.
Celecoxib Inhibits Interleukin-6/Interleukin-6 Receptor-Induced JAK2/STAT3 Phosphorylation in Human Hepatocellular Carcinoma Cells.
Y. Liu, A. Liu, H. Li, C. Li, and J. Lin (2011)
Cancer Prevention Research
4, 1296-1305
|Abstract »|Full Text »|PDF »
Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells.
M. Jinushi, S. Chiba, H. Yoshiyama, K. Masutomi, I. Kinoshita, H. Dosaka-Akita, H. Yagita, A. Takaoka, and H. Tahara (2011)
PNAS
108, 12425-12430
|Abstract »|Full Text »|PDF »
Rapid growth of a hepatocellular carcinoma and the driving mutations revealed by cell-population genetic analysis of whole-genome data.
Y. Tao, J. Ruan, S.-H. Yeh, X. Lu, Y. Wang, W. Zhai, J. Cai, S. Ling, Q. Gong, Z. Chong, et al. (2011)
PNAS
108, 12042-12047
|Abstract »|Full Text »|PDF »
Aflatoxin B1-DNA Adduct Formation and Mutagenicity in Livers of Neonatal Male and Female B6C3F1 Mice.
L. L. Woo, P. A. Egner, C. L. Belanger, R. Wattanawaraporn, L. J. Trudel, R. G. Croy, J. D. Groopman, J. M. Essigmann, and G. N. Wogan (2011)
Toxicol. Sci.
122, 38-44
|Abstract »|Full Text »|PDF »
HER2 Overexpression Elicits a Proinflammatory IL-6 Autocrine Signaling Loop That Is Critical for Tumorigenesis.
Z. C. Hartman, X.-Y. Yang, O. Glass, G. Lei, T. Osada, S. S. Dave, M. A. Morse, T. M. Clay, and H. K. Lyerly (2011)
Cancer Res.
71, 4380-4391
|Abstract »|Full Text »|PDF »
Intratumoral Administration of TLR4 Agonist Absorbed into a Cellular Vector Improves Antitumor Responses.
M. B. Davis, D. Vasquez-Dunddel, J. Fu, E. Albesiano, D. Pardoll, and Y. J. Kim (2011)
Clin. Cancer Res.
17, 3984-3992
|Abstract »|Full Text »|PDF »
Chronic Inflammatory IFN-{gamma} Signaling Suppresses Hepatocarcinogenesis in Mice by Sensitizing Hepatocytes for Apoptosis.
S. Luth, J. Schrader, S. Zander, A. Carambia, J. Buchkremer, S. Huber, K. Reifenberg, K.-I. Yamamura, P. Schirmacher, A. W. Lohse, et al. (2011)
Cancer Res.
71, 3763-3771
|Abstract »|Full Text »|PDF »
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion.
The role of JNK in the development of hepatocellular carcinoma.
M. Das, D. S. Garlick, D. L. Greiner, and R. J. Davis (2011)
Genes & Dev.
25, 634-645
|Abstract »|Full Text »|PDF »
Preventive Effects of (-)-Epigallocatechin Gallate on Diethylnitrosamine-Induced Liver Tumorigenesis in Obese and Diabetic C57BL/KsJ-db/db Mice.
M. Shimizu, H. Sakai, Y. Shirakami, Y. Yasuda, M. Kubota, D. Terakura, A. Baba, T. Ohno, Y. Hara, T. Tanaka, et al. (2011)
Cancer Prevention Research
4, 396-403
|Abstract »|Full Text »|PDF »
Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage.
Interleukin 6, but Not T Helper 2 Cytokines, Promotes Lung Carcinogenesis.
C. E. Ochoa, S. G. Mirabolfathinejad, V. A. Ruiz, S. E. Evans, M. Gagea, C. M. Evans, B. F. Dickey, and S. J. Moghaddam (2011)
Cancer Prevention Research
4, 51-64
|Abstract »|Full Text »|PDF »
Acyclic Retinoid Inhibits Diethylnitrosamine-Induced Liver Tumorigenesis in Obese and Diabetic C57BLKS/J- +Leprdb/+Leprdb Mice.
M. Shimizu, H. Sakai, Y. Shirakami, J. Iwasa, Y. Yasuda, M. Kubota, K. Takai, H. Tsurumi, T. Tanaka, and H. Moriwaki (2011)
Cancer Prevention Research
4, 128-136
|Abstract »|Full Text »|PDF »
Isoflurane activates intestinal sphingosine kinase to protect against bilateral nephrectomy-induced liver and intestine dysfunction.
M. Kim, S. W. Park, M. Kim, V. D. D'Agati, and H. T. Lee (2011)
Am J Physiol Renal Physiol
300, F167-F176
|Abstract »|Full Text »|PDF »
gp130 at the nexus of inflammation, autoimmunity, and cancer.
A. Pedram, M. Razandi, F. O'Mahony, D. Lubahn, and E. R. Levin (2010)
Mol. Endocrinol.
24, 2152-2165
|Abstract »|Full Text »|PDF »
Sexually Dimorphic Actions of Glucocorticoids Provide a Link to Inflammatory Diseases with Gender Differences in Prevalence.
D. Duma, J. B. Collins, J. W. Chou, and J. A. Cidlowski (2010)
Science Signaling
3, ra74
|Abstract »|Full Text »|PDF »
B7-H1-Dependent Sex-Related Differences in Tumor Immunity and Immunotherapy Responses.
P.-Y. Lin, L. Sun, S. R. Thibodeaux, S. M. Ludwig, R. K. Vadlamudi, V. J. Hurez, R. Bahar, M. J. Kious, C. B. Livi, S. R. Wall, et al. (2010)
J. Immunol.
185, 2747-2753
|Abstract »|Full Text »|PDF »
Inhibition of STAT3 Signaling Blocks the Anti-apoptotic Activity of IL-6 in Human Liver Cancer Cells.
Y. Liu, P.-K. Li, C. Li, and J. Lin (2010)
J. Biol. Chem.
285, 27429-27439
|Abstract »|Full Text »|PDF »
MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18.
R. Salcedo, A. Worschech, M. Cardone, Y. Jones, Z. Gyulai, R.-M. Dai, E. Wang, W. Ma, D. Haines, C. O'hUigin, et al. (2010)
J. Exp. Med.
207, 1625-1636
|Abstract »|Full Text »|PDF »
Estrogen Receptors and Endothelium.
J.-F. Arnal, C. Fontaine, A. Billon-Gales, J. Favre, H. Laurell, F. Lenfant, and P. Gourdy (2010)
Arterioscler Thromb Vasc Biol
30, 1506-1512
|Abstract »|Full Text »|PDF »
E. M. Michalak, C. J. Vandenberg, A. R. D. Delbridge, L. Wu, C. L. Scott, J. M. Adams, and A. Strasser (2010)
Genes & Dev.
24, 1608-1613
|Abstract »|Full Text »|PDF »
Ontogenetic Complexity of Sexual Dimorphism and Sex-Specific Selection.
J. E. Mank, K. Nam, B. Brunstrom, and H. Ellegren (2010)
Mol. Biol. Evol.
27, 1570-1578
|Abstract »|Full Text »|PDF »
Toll-Like Receptor 6 Ser249Pro Polymorphism Is Associated With Lower Left Ventricular Wall Thickness and Inflammatory Response in Hypertensive Women.
M. L. Sales, R. Schreiber, M. C. S. Ferreira-Sae, M. N. Fernandes, C. S. C. Piveta, J. A. A. Cipolli, C. C. Cardoso, J. R. Matos-Souza, B. Geloneze, K. G. Franchini, et al. (2010)
Am J Hypertens
23, 649-654
|Abstract »|Full Text »|PDF »
Resveratrol Suppresses Oxidative Stress and Inflammatory Response in Diethylnitrosamine-Initiated Rat Hepatocarcinogenesis.
A. Bishayee, K. F. Barnes, D. Bhatia, A. S. Darvesh, and R. T. Carroll (2010)
Cancer Prevention Research
3, 753-763
|Abstract »|Full Text »|PDF »
Distinct populations of metastases-enabling myeloid cells expand in the liver of mice harboring invasive and preinvasive intra-abdominal tumor.
M. K. Connolly, J. Mallen-St. Clair, A. S. Bedrosian, A. Malhotra, V. Vera, J. Ibrahim, J. Henning, H. L. Pachter, D. Bar-Sagi, A. B. Frey, et al. (2010)
J. Leukoc. Biol.
87, 713-725
|Abstract »|Full Text »|PDF »
Toll-like Receptor 3-Mediated Suppression of TRAMP Prostate Cancer Shows the Critical Role of Type I Interferons in Tumor Immune Surveillance.
A. I. Chin, A. K. Miyahira, A. Covarrubias, J. Teague, B. Guo, P. W. Dempsey, and G. Cheng (2010)
Cancer Res.
70, 2595-2603
|Abstract »|Full Text »|PDF »
Interleukin-6: a therapeutic Jekyll and Hyde in gastrointestinal and hepatic diseases.
CADPE Suppresses Cyclin D1 Expression in Hepatocellular Carcinoma by Blocking IL-6-induced STAT3 Activation.
C. WON, C. S. LEE, J.-K. LEE, T.-J. KIM, K.-H. LEE, Y. M. YANG, Y.-N. KIM, S.-K. YE, and M.-H. CHUNG (2010)
Anticancer Res
30, 481-488
|Abstract »|Full Text »|PDF »
Nuclear Factor-{kappa}B and Tumor-Associated Macrophages.
Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens.
J G Fox, Y Feng, E J Theve, A R Raczynski, J L A Fiala, A L Doernte, M Williams, J L McFaline, J M Essigmann, D B Schauer, et al. (2010)
Gut
59, 88-97
|Abstract »|Full Text »|PDF »
The Aryl Hydrocarbon Receptor Functions as a Tumor Suppressor of Liver Carcinogenesis.
Y. Fan, G. P. Boivin, E. S. Knudsen, D. W. Nebert, Y. Xia, and A. Puga (2010)
Cancer Res.
70, 212-220
|Abstract »|Full Text »|PDF »
Hepatocellular carcinoma for the non-specialist.
T Kumagi, Y Hiasa, and G M Hirschfield (2009)
BMJ
339, b5039
|Full Text »
Chronic lymphocytic leukemia of E{micro}-TCL1 transgenic mice undergoes rapid cell turnover that can be offset by extrinsic CD257 to accelerate disease progression.
T. Enzler, A. P. Kater, W. Zhang, G. F. Widhopf II, H.-Y. Chuang, J. Lee, E. Avery, C. M. Croce, M. Karin, and T. J. Kipps (2009)
Blood
114, 4469-4476
|Abstract »|Full Text »|PDF »
NF-{kappa}B as a Critical Link Between Inflammation and Cancer.
S. Seshadri, Y. Kannan, S. Mitra, J. Parker-Barnes, and M. D. Wewers (2009)
J. Immunol.
183, 5358-5368
|Abstract »|Full Text »|PDF »
Gender Disparities in Metastatic Colorectal Cancer Survival.
A. Hendifar, D. Yang, F. Lenz, G. Lurje, A. Pohl, C. Lenz, Y. Ning, W. Zhang, and H.-J. Lenz (2009)
Clin. Cancer Res.
15, 6391-6397
|Abstract »|Full Text »|PDF »
Influence of interleukin-6 G-174C gene polymorphism on coronary artery disease, cardiovascular complications and mortality in dialysis patients.
S. Aker, C. Bantis, P. Reis, N. Kuhr, C. Schwandt, B. Grabensee, P. Heering, and K. Ivens (2009)
Nephrol. Dial. Transplant.
24, 2847-2851
|Abstract »|Full Text »|PDF »
The Constitutive Active/Androstane Receptor Facilitates Unique Phenobarbital-Induced Expression Changes of Genes Involved in Key Pathways in Precancerous Liver and Liver Tumors.
J. M. Phillips, L. D. Burgoon, and J. I. Goodman (2009)
Toxicol. Sci.
110, 319-333
|Abstract »|Full Text »|PDF »
Hepatitis B Virus Infection and Hepatocellular Carcinoma Among Parous Taiwanese Women: Nationwide Cohort Study.
C.-W. Fwu, Y.-C. Chien, G. D. Kirk, K. E. Nelson, S.-L. You, H.-S. Kuo, M. Feinleib, and C.-J. Chen (2009)
J Natl Cancer Inst
101, 1019-1027
|Abstract »|Full Text »|PDF »
Estrogen Inhibits ATR Signaling to Cell Cycle Checkpoints and DNA Repair.
A. Pedram, M. Razandi, A. J. Evinger, E. Lee, and E. R. Levin (2009)
Mol. Biol. Cell
20, 3374-3389
|Abstract »|Full Text »|PDF »
Obesity Impairs Wound Healing in Ovariectomized Female Mice.
V. B. HOLCOMB, V. A. KECK, J. C. BARRETT, J. HONG, S. K. LIBUTTI, and N. P. NUNEZ (2009)
In Vivo
23, 515-518
|Abstract »|Full Text »|PDF »
The Epidermal Growth Factor Receptor: A Link Between Inflammation and Liver Cancer.
C. Berasain, M. J. Perugorria, M. U. Latasa, J. Castillo, S. Goni, M. Santamaria, J. Prieto, and M. A. Avila (2009)
Exp Biol Med
234, 713-725
|Abstract »|Full Text »|PDF »
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability.
F. Colotta, P. Allavena, A. Sica, C. Garlanda, and A. Mantovani (2009)
Carcinogenesis
30, 1073-1081
|Abstract »|Full Text »|PDF »
Milk fat globule epidermal growth factor-8 blockade triggers tumor destruction through coordinated cell-autonomous and immune-mediated mechanisms.
M. Jinushi, M. Sato, A. Kanamoto, A. Itoh, S. Nagai, S. Koyasu, G. Dranoff, and H. Tahara (2009)
J. Exp. Med.
206, 1317-1326
|Abstract »|Full Text »|PDF »
Toll-like receptors as targets in chronic liver diseases.
Molecular insights into {beta}-galactoside {alpha}2,6-sialyltransferase secretion in vivo.
S. Kitazume, R. Oka, K. Ogawa, S. Futakawa, Y. Hagiwara, H. Takikawa, M. Kato, A. Kasahara, E. Miyoshi, N. Taniguchi, et al. (2009)
Glycobiology
19, 479-487
|Abstract »|Full Text »|PDF »
C/EBP{beta} regulates body composition, energy balance-related hormones and tumor growth.
J. Staiger, M. J. Lueben, D. Berrigan, R. Malik, S. N. Perkins, S. D. Hursting, and P. F. Johnson (2009)
Carcinogenesis
30, 832-840
|Abstract »|Full Text »|PDF »
Predominant modifier of extreme liver cancer susceptibility in C57BR/cdJ female mice localized to 6 Mb on chromosome 17.
S. E.-M. Peychal, A. Bilger, H. C. Pitot, and N. R. Drinkwater (2009)
Carcinogenesis
30, 879-885
|Abstract »|Full Text »|PDF »
Sex-Modified Effect of Hepatitis B Virus Infection on Mortality From Primary Liver Cancer.
N. Wang, Y. Zheng, X. Yu, W. Lin, Y. Chen, and Q. Jiang (2009)
Am. J. Epidemiol.
169, 990-995
|Abstract »|Full Text »|PDF »